Cargando…
An adaptive power prior for sequential clinical trials – Application to bridging studies
During drug evaluation trials, information from clinical trials previously conducted on another population, indications or schedules may be available. In these cases, it might be desirable to share information by efficiently using the available resources. In this work, we developed an adaptive power...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433690/ https://www.ncbi.nlm.nih.gov/pubmed/31729275 http://dx.doi.org/10.1177/0962280219886609 |
_version_ | 1783572006004850688 |
---|---|
author | Ollier, Adrien Morita, Satoshi Ursino, Moreno Zohar, Sarah |
author_facet | Ollier, Adrien Morita, Satoshi Ursino, Moreno Zohar, Sarah |
author_sort | Ollier, Adrien |
collection | PubMed |
description | During drug evaluation trials, information from clinical trials previously conducted on another population, indications or schedules may be available. In these cases, it might be desirable to share information by efficiently using the available resources. In this work, we developed an adaptive power prior with a commensurability parameter for using historical or external information. It allows, at each stage, full borrowing when the data are not in conflict, no borrowing when the data are in conflict or “tuned” borrowing when the data are in between. We propose to apply our adaptive power prior method to bridging studies between Caucasians and Asians, and we focus on the sequential adaptive allocation design, although other design settings can be used. We weight the prior information in two steps: the effective sample size approach is used to set the maximum desirable amount of information to be shared from historical data at each step of the trial; then, in a sort of Empirical Bayes approach, a commensurability parameter is chosen using a measure of distribution distance. This approach avoids elicitation and computational issues regarding the usual Empirical Bayes approach. We propose several versions of our method, and we conducted an extensive simulation study evaluating the robustness and sensitivity to prior choices. |
format | Online Article Text |
id | pubmed-7433690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74336902020-09-04 An adaptive power prior for sequential clinical trials – Application to bridging studies Ollier, Adrien Morita, Satoshi Ursino, Moreno Zohar, Sarah Stat Methods Med Res Articles During drug evaluation trials, information from clinical trials previously conducted on another population, indications or schedules may be available. In these cases, it might be desirable to share information by efficiently using the available resources. In this work, we developed an adaptive power prior with a commensurability parameter for using historical or external information. It allows, at each stage, full borrowing when the data are not in conflict, no borrowing when the data are in conflict or “tuned” borrowing when the data are in between. We propose to apply our adaptive power prior method to bridging studies between Caucasians and Asians, and we focus on the sequential adaptive allocation design, although other design settings can be used. We weight the prior information in two steps: the effective sample size approach is used to set the maximum desirable amount of information to be shared from historical data at each step of the trial; then, in a sort of Empirical Bayes approach, a commensurability parameter is chosen using a measure of distribution distance. This approach avoids elicitation and computational issues regarding the usual Empirical Bayes approach. We propose several versions of our method, and we conducted an extensive simulation study evaluating the robustness and sensitivity to prior choices. SAGE Publications 2019-11-15 2020-08 /pmc/articles/PMC7433690/ /pubmed/31729275 http://dx.doi.org/10.1177/0962280219886609 Text en © The Author(s) 2019 https://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Ollier, Adrien Morita, Satoshi Ursino, Moreno Zohar, Sarah An adaptive power prior for sequential clinical trials – Application to bridging studies |
title | An adaptive power prior for sequential clinical trials – Application to bridging studies |
title_full | An adaptive power prior for sequential clinical trials – Application to bridging studies |
title_fullStr | An adaptive power prior for sequential clinical trials – Application to bridging studies |
title_full_unstemmed | An adaptive power prior for sequential clinical trials – Application to bridging studies |
title_short | An adaptive power prior for sequential clinical trials – Application to bridging studies |
title_sort | adaptive power prior for sequential clinical trials – application to bridging studies |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433690/ https://www.ncbi.nlm.nih.gov/pubmed/31729275 http://dx.doi.org/10.1177/0962280219886609 |
work_keys_str_mv | AT ollieradrien anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT moritasatoshi anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT ursinomoreno anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT zoharsarah anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT ollieradrien adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT moritasatoshi adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT ursinomoreno adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies AT zoharsarah adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies |